We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Algeta Announces first US Patient Randomized in ALSYMPCA Phase III Study

News   Dec 16, 2009

 
Algeta Announces first US Patient Randomized in ALSYMPCA Phase III Study
 
 
 

RELATED ARTICLES

Proactive Approach Protects Population From HIV

News

A preventative approach to HIV drastically reduced the number of HIV diagnoses in New South Wales, Australia.

READ MORE

Marker May Help Target Treatments for Crohn’s Patients

News

Accurately predicting which subtype of Crohn's disease is likely to develop has not been possible, until now.

READ MORE

Treatment Eliminates Nicotine Addiction in Preclinical Tests

News

Scientists at Scripps Research have successfully tested a potential new smoking-cessation treatment in rodents.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE